FITLIFE BRANDS, INC.

FTLF ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Revenue $81.5M $64.5M $52.7M $28.8M $27.9M $21.7M $19.5M $17.1M
Cost of Revenue $50.0M $36.4M $31.3M $16.8M $15.4M $12.4M $11.4M $10.3M
Gross Profit $31.5M $28.1M $21.4M $12.0M $12.5M $9.5M $8.0M $6.7M
Gross Margin 38.6% 43.6% 40.7% 41.8% 44.8% 43.9% 40.9% 39.5%
Operating Expenses
Research & Development
SG&A Expense $14.0M $10.0M $7.9M $6.0M $6.2M $3.0M $3.0M $3.3M
Operating Income $10.1M $13.1M $7.6M $5.7M $6.2M $4.3M $2.5M $653.0K
Operating Margin 12.4% 20.3% 14.3% 19.8% 22.3% 20.0% 12.8% 3.8%
Interest Expense $1.0M $0 $15.0K $47.0K $133.0K
Pretax Income $8.2M $11.9M $7.0M $5.8M $6.7M $4.4M $2.6M $520.0K
Income Tax Expense $1.9M $2.9M $1.7M $1.4M $1.3M $-4.4M $7.0K $11.0K
Net Income $6.3M $9.0M $5.3M $4.4M $5.4M $8.8M $2.6M $509.0K
Net Margin 7.8% 13.9% 10.0% 15.4% 19.4% 40.6% 13.4% 3.0%
EPS (Basic) $0.68 $0.98 $0.59 $0.97 $1.23 $2.08 $0.62 $0.09
EPS (Diluted) $0.63 $0.91 $0.54 $0.89 $1.13 $1.94 $0.58 $0.09
Shares Outstanding (Basic) 9.3M 9.2M 9.0M 4.6M 4.4M 4.2M 4.1M 4.4M
Shares Outstanding (Diluted) 10.0M 9.9M 9.8M 5.0M 4.8M 4.5M 4.4M 4.4M
Dividends Per Share
← Newer Page 1 of 2 Older →